Wondmagegn Yenesew Mihret, Girmay Getu, Amare Gashaw Azanaw, Assefa Muluneh, Tamir Mebratu, Abriham Zufan Yiheyis, Setegn Abebaw
Department of Medical Parasitology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Department of Immunology and Molecular Biology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
BMC Infect Dis. 2025 Jan 3;25(1):20. doi: 10.1186/s12879-024-10432-x.
Gastrointestinal infections caused by intestinal parasites and Helicobacter pylori are significant public health issues in Africa, where poor sanitation and limited access to healthcare contribute to high disease burden. Since there was no previous pooled data regarding the intestinal parasites and Helicobacter pylori co-infections among gastrointestinal symptomatic patients in the African context, this review aimed to determine the overall prevalence of intestinal parasites and Helicobacter pylori co-infection in people with gastrointestinal symptoms in Africa.
The current review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) standards and registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD42024598993). A comprehensive search was conducted across electronic databases: PubMed, Medline, EMBASE, Google Scholar, Web of Science, Science Direct, and African Journals Online. The data was extracted using Microsoft Excel 2010 and analyzed using STATA version 11.0 Software. A random-effects model was used to calculate the pooled effect size of outcome variables across studies, with a 95% confidence interval. The I statistic was employed to assess heterogeneity. A funnel plot and Egger's test were used to identify publication bias. A p-value < 0.05 indicated statistically significant publication bias.
The combined prevalence of intestinal parasites and H. pylori co-infections was 31.03% (95% CI: 18.66-43.39) with significant heterogeneity (I = 98.9%, p = 0.000). The Subgroup analysis revealed that Egypt and Ethiopia had the highest and lowest rates of intestinal parasites and H. pylori co-infection respectively at 39.84% (95% CI: 27.79-51.88%), and 5.86% (95% CI: 4.10-7.62). Moreover, the adjusted Egger's regression test did not reveal any publication bias (p = 0.116).
This meta-analysis shows a significant prevalence of intestinal parasites and H. pylori co-infection in Africans with gastrointestinal symptoms. The coexistence of these diseases creates diagnostic and therapeutic problems. Thus, the findings underscore need for targeted interventions and further research is needed to develop effective control strategies to reduce the impact of these illnesses on public health in Africa.
由肠道寄生虫和幽门螺杆菌引起的胃肠道感染是非洲重大的公共卫生问题,当地卫生条件差和医疗服务可及性有限导致疾病负担沉重。由于此前尚无关于非洲有胃肠道症状患者中肠道寄生虫与幽门螺杆菌合并感染的汇总数据,本综述旨在确定非洲有胃肠道症状人群中肠道寄生虫与幽门螺杆菌合并感染的总体患病率。
本综述遵循系统评价和Meta分析的首选报告项目(PRISMA)标准,并在国际系统评价前瞻性注册库(PROSPERO;CRD42024598993)中注册。对电子数据库进行了全面检索:PubMed、Medline、EMBASE、谷歌学术、科学网、Science Direct和非洲期刊在线。使用Microsoft Excel 2010提取数据,并使用STATA 11.0软件进行分析。采用随机效应模型计算各研究中结局变量的合并效应量,并给出95%置信区间。采用I统计量评估异质性。使用漏斗图和Egger检验识别发表偏倚。p值<0.05表示存在统计学显著的发表偏倚。
肠道寄生虫与幽门螺杆菌合并感染的综合患病率为31.03%(95%置信区间:18.66 - 43.39),异质性显著(I = 98.9%,p = 0.000)。亚组分析显示,埃及和埃塞俄比亚的肠道寄生虫与幽门螺杆菌合并感染率分别最高和最低,为39.84%(95%置信区间:27.7